Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Daniel Park Profile picture
@Daniel_E_Park
Feb 26, 2024 • 4 tweets • 3 min read • Read on X
Just released: Pretty remarkable 1-year durability data for Novavax 2-dose primary series. Though there is some expected waning, there was >65% efficacy at 1y (mRNA options typically wane to this level by ~4-5 months). Also fewer waning differences by age.
sciencedirect.com/science/articl…
Image
Refs:
NVX:
BNT:
Waning:
sciencedirect.com/science/articl…
sciencedirect.com/science/articl…
thelancet.com/journals/lanre…
To illustrate age stratified data, I took NVX data from the Japan paper and compared w/ a BNT paper from Norway. For BNT, nAbs & IgG largely back to baseline levels in older individuals by 5m, but remain at protective level at 1y w/ NVX, and more similar to young ages throughout. Image
Long-term durability is challenging to assess due to hybrid immunity, mutations, etc. More long-term durability studies are needed. But this adds to evidence from other observational data and animal models re: NVX durability

jamanetwork.com/journals/jaman…
nature.com/articles/s4146…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Daniel Park

Daniel Park Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Daniel_E_Park

Daniel Park Profile picture
Feb 23
New RCT comparing Moderna bivalent and Novavax (original strain) as a fourth dose. Novavax has:
- lower side effects
- similar cell mediated immunity, lower IgG response
- potentially broader protection vs variants Image
Link to study:

Side effects are a leading cause of vaccine hesitancy. The Novavax reactogenicity shows roughly half the frequency of each symptom, and lower severity. journalofinfection.com/article/S0163-…Image
The IgG responses are lower with the novavax vaccine, as consistent with prior studies. The authors note that these differences may not be meaningful as other RCTs and studies show similar efficacy with these differences in IgG levels. Image
Read 6 tweets
Daniel Park Profile picture
Feb 16
Having worked with many EIS officers, I can confirm they are among the best and brightest. They leave high-paying jobs to serve communities, ready to face danger at a moment’s notice. Now, the entire class has been let go. These heroes won’t be there when we need them.
One particular memory of mine that highlights the character of an EIS officer. We were on call with an EIS grad while he was in the field. Heard screeching tires and the line went dead. Called his cell, and he picked up and said calmly, "Hi, it's [name]".
I said, "oh we were worried you were in a car accident".
He said, "yeah I was. Our car flipped over. Let me call you back, I need to help our driver and check on the other car".
Read 6 tweets
Daniel Park Profile picture
Feb 1
Results from PREVENT-19 Novavax pediatric RCT of >1,000 adolescents.
- Vaccine efficacy was 74% (original Wuhan vax vs Delta variant).
- Nearly all infections after vaccination were asymptomatic or very mild.
- Viral load lower in vaccinated, but not statistically significant Image
Notably, this study used twice-weekly swabs to detect asymptomatic infections. Not directly comparable, but Moderna had 39% efficacy vs. asymptomatic infections in adolescents. Ad.26 was lower at 29%.
nejm.org/doi/10.1056/NE…
nejm.org/doi/10.1056/NE… Image
BNT (Pfizer) had 87% efficacy w/ less freq sampling (weekly), but with an asymptomatic proportion (~38%) suggesting some asymptomatic infections were potentially missed.
Read 5 tweets
Daniel Park Profile picture
Jan 17
Recent RCT: Co-administering NVX (COVID) & PCV20 (Pneumococcal) vaccines is as effective as when given separately, with no extra side effects.
This is key, as both diseases are major killers, and PCV may also reduce severe COVID by reducing pneumococcal carriage (🧵on this below) Image
Link to paper: journalofinfection.com/article/S0163-…
SARS-CoV-2 & S. pneumo can increase severity together. Early in the pandemic, we used endemic hCoV data to explore risk factors for severe illness. We found high-density S. pneumo carriage increased the risk of severe disease w/ concurrent hCoV infection.
journals.lww.com/pidj/fulltext/…Image
Read 10 tweets
Daniel Park Profile picture
Dec 28, 2024
Nice coverage from Vox on some of the benefits of the Novavax COVID vaccine: similar effectiveness, fewer side effects, and potentially longer lasting protection. Image
Since concerns about the mRNA platform and side effects are leading causes of vaccine hesitancy, increasing awareness will increase uptake and have societal benefits.
Link to article: vox.com/even-better/39…
I've also found it effective to point out the novavax vaccine has similar side effects to routinely used vaccines that almost everyone has already received
Read 5 tweets
Daniel Park Profile picture
Dec 24, 2024
Epidemiologists did remarkable work in the early days of COVID-19. Within months, they:
- Accurately predicted the timing of every major wave for the next 3 years.
- Warned SARS-CoV-2 would likely become endemic.
- Identified risk of aerosol transmission.
We knew from day 1 that airborne transmission was likely (like SARS-CoV-1).
As confusion w/ masks grew, we saw the urgent need to provide clarity on ventilation (e g. Excerpt from Drs. Prather @kprather88 and Milton, Oct 2020)
science.org/doi/10.1126/sc…
nejm.org/doi/full/10.10… Image
Image
Leading epidemiologists also noted that herd immunity targets were likely unattainable for eliminating the virus through vaccination.
E g. excerpt from a Dec 2020 interview (prior to vaccine rollout)
edhub.ama-assn.org/jn-learning/vi…Image
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

Send Email!

:(